Health Systems and Policy

The Health Systems and Policy group develops and applies methods to evaluate and validate health system interventions in real-world health systems. We place particular emphasis on measuring systems effectiveness of essential health interventions and assessing policies, recognising that all health system building blocks – governance, financing, human resources, informatics, technologies, infrastructure and service delivery – are interrelated. We also focus on strengthening good governance of health systems and translating evidence into policy. Our research group brings together expertise in health systems analysis, policy analysis and evaluation, and health economics.

CHEPSAA

We have been involved in the Consortium for Health Policy and Systems Analysis for Africa, an EU FP7 project to support teaching in schools of public health in Africa and beyond. Read more

Fabrizio Tediosi

Fabrizio Tediosi

Prof. Dr.

Head of Health Systems and Policies
+41612848719
fabrizio.tediosi@swisstph.ch

Antillon M et al. Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo. PLoS Negl Trop Dis. 2026;20(10). DOI: 10.1371/journal.pntd.0014777

Ehteshami F, Tediosi F, Fink G, Muñoz D.C. Exploring underlying factors associated with effective coverage of diabetes care in Iran: a systems thinking approach. BMC Health Serv Res. 2026;26. DOI: 10.1186/s12913-026-15160-3

Ehteshami F, Verjans A, Cassidy R, Tediosi F, Fink G, Cobos Muñoz D. A realist review to understand the complexity of effective management of type 2 diabetes and hypertension. Public Health Rev. 2026;47:1608655. DOI: 10.3389/phrs.2026.1608655

Harkare H.V et al. Implementation of WHO-PEN interventions in Eswatini: an assessment of health equity and out-of-pocket expenditure for diabetes and hypertension care. Int J Equity Health. 2026;25:119. DOI: 10.1186/s12939-026-02829-8

Harkare H.V et al. Comparative cost analysis of community-based tuberculosis screening: Computer-Aided Detection (CAD) alone versus CAD with point-of-care C-reactive protein testing in South Africa and Lesotho. PLOS Glob Public Health. 2026;6(9):e0007341. DOI: 10.1371/journal.pgph.0007341

Huang C.I et al. Transmission and cost-effectiveness modelling to estimate the progress towards elimination and future strategy optimisation for gambiense human African trypanosomiasis in Uganda. BMC Infect Dis. 2026;26. DOI: 10.1186/s12879-026-13581-3